Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (111-120 of 368) with videos related to

Pageof 37
Sort By:
The Journal of Infectious Diseases|July 26, 2020
Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected SamplesBeth Catlett, Sahar Bajis, Mitchell Starr, et al.
The International Journal on Drug Policy|June 11, 2019
Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, CanadaMarion Selfridge, Evan B Cunningham, Rozalyn Milne, et al.
Journal of Hepatology|February 8, 2017
Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis CJason Grebely, Tracy Swan, Matthew Hickman, et al.
The International Journal on Drug Policy|September 15, 2007
Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infectionJason Grebely, Krista Genoway, Milan Khara, et al.
The International Journal on Drug Policy|April 26, 2024
Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisonsRugi Bah, Yumi Sheehan, Xiaoying Li, et al.
The International Journal on Drug Policy|September 14, 2021
Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, CanadaEmmanuel Fortier, Stine Bordier Høj, Marie-Pierre Sylvestre, et al.
Journal of Hepatology|May 13, 2019
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, AustraliaMaryam Alavi, Matthew G Law, Heather Valerio, et al.
Drug and Alcohol Dependence|June 1, 2025
Sexually transmitted infection prevalence and testing coverage among people who inject drugs: A systematic reviewOlivia Price, Paige Webb, Jason Grebely, et al.
BMC Infectious Diseases|May 11, 2018
Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012Maryam Alavi, Jason Grebely, Behzad Hajarizadeh, et al.
Journal of Hepatology|August 30, 2016
Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014)Reem Waziry, Jason Grebely, Janaki Amin, et al.
Pageof 37

Showing results (111-120 of 368) with videos related to

Sort By:
Pageof 37
The Journal of Infectious Diseases|July 26, 2020
Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected SamplesBeth Catlett, Sahar Bajis, Mitchell Starr, et al.
The International Journal on Drug Policy|June 11, 2019
Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, CanadaMarion Selfridge, Evan B Cunningham, Rozalyn Milne, et al.
Journal of Hepatology|February 8, 2017
Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis CJason Grebely, Tracy Swan, Matthew Hickman, et al.
The International Journal on Drug Policy|September 15, 2007
Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infectionJason Grebely, Krista Genoway, Milan Khara, et al.
The International Journal on Drug Policy|April 26, 2024
Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisonsRugi Bah, Yumi Sheehan, Xiaoying Li, et al.
The International Journal on Drug Policy|September 14, 2021
Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, CanadaEmmanuel Fortier, Stine Bordier Høj, Marie-Pierre Sylvestre, et al.
Journal of Hepatology|May 13, 2019
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, AustraliaMaryam Alavi, Matthew G Law, Heather Valerio, et al.
Drug and Alcohol Dependence|June 1, 2025
Sexually transmitted infection prevalence and testing coverage among people who inject drugs: A systematic reviewOlivia Price, Paige Webb, Jason Grebely, et al.
BMC Infectious Diseases|May 11, 2018
Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012Maryam Alavi, Jason Grebely, Behzad Hajarizadeh, et al.
Journal of Hepatology|August 30, 2016
Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014)Reem Waziry, Jason Grebely, Janaki Amin, et al.
Pageof 37